Molecular subgroups of adult medulloblastoma: A long-term single-institution study

Neuro-Oncology

Volumn 18, Issue 7, 2016, Pages 982-990

  Zhao, Fu ^a,b   Ohgaki, Hiroko ^c   Xu, Lei ^d   Giangaspero, Felice ^e   Li, Chunde ^b   Li, Peng ^b   Yang, Zhijun ^b   Wang, Bo ^b   Wang, Xingchao ^b   Wang, Zhenmin ^b   Ai, Lin ^b   Zhang, Jing ^a   Luo, Lin ^a   Liu, Pinan ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

adult medulloblastoma; histology; molecular subgroup; prognosis; survival

Indexed keywords

SONIC HEDGEHOG PROTEIN; WNT PROTEIN; BETA CATENIN; CTNNB1 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ADULTHOOD; ARTICLE; CANCER PROGNOSIS; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEDULLOBLASTOMA; MOLECULAR GENETICS; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; TUMOR CLASSIFICATION; ADOLESCENT; CEREBELLAR NEOPLASMS; DISEASE COURSE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROGNOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; BETA CATENIN; BIOMARKERS, TUMOR; CEREBELLAR NEOPLASMS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEDGEHOG PROTEINS; HUMANS; LONGITUDINAL STUDIES; MALE; MEDULLOBLASTOMA; MIDDLE AGED; PROGNOSIS; WNT PROTEINS; YOUNG ADULT;

EID: 84977578608     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/now050     Document Type: Article

References (29)

1. Giordana MT, Schiffer P, Lanotte M, et al. Epidemiology of adult medulloblastoma. Int J Cancer. 1999;80(5):689-692.
2. Polkinghorn WR, Tarbell NJ. Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification. Nat Clin Pract Oncol. 2007;4(5):295-304.
3. Packer RJ, Gajjar A, Vezina G, et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol. 2006; 24(25):4202-4208.
4. Taylor RE, Bailey CC, Robinson K, et al. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study. J Clin Oncol. 2003;21(8):1581-1591.
5. Gajjar A, ChintagumpalaM, Ashley D, et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol. 2006;7(10):813-820.
6. Kool M, Korshunov A, Remke M, et al. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol. 2012;123(4): 473-484.
7. Northcott PA, Korshunov A, Witt H, et al. Medulloblastoma comprises four distinct molecular variants. J Clin Oncol. 2011; 29(11):1408-1414.
8. Ellison DW, Dalton J, Kocak M, et al. Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Acta Neuropathol. 2011;121(3):381-396.
9. Rudin CM, Hann CL, Laterra J, et al. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med. 2009; 361(12):1173-1178.
10. Remke M, Hielscher T, Korshunov A, et al. FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma. J Clin Oncol. 2011;29(29):3852-3861.
11. Padovani L, Sunyach MP, Perol D, et al. Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults. Int J Radiat Oncol Biol Phys. 2007;68(2):433-440.
12. Kunschner LJ, Kuttesch J, Hess K, et al. Survival and recurrence factors in adult medulloblastoma: the M.D. Anderson Cancer Center experience from 1978 to 1998. Neuro Oncol. 2001;3(3): 167-173.
13. Lai R. Survival of patients with adult medulloblastoma: a population-based study. Cancer. 2008;112(7):1568-1574.
14. Korshunov A, Remke M, Werft W, et al. Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification. J Clin Oncol. 2010; 28(18):3054-3060.
15. Rodriguez FJ, Eberhart C, O'Neill BP, et al. Histopathologic grading of adult medulloblastomas. Cancer. 2007;109(12):2557-2565.
16. Giangaspero F, Eberhart CG, Haapasalo H, et al. Medulloblastoma. In: Louis DN, Ohgaki H, Wiestler OD, et al., eds. WHO Classification of Tumours of the Central Nervous System. Lyon, France: International Agency for Research on Cancer; 2007:132-140.
17. Chang CH, Housepian EM, Herbert C Jr. An operative staging system and a megavoltage radiotherapeutic technic [sic] for cerebellar medulloblastomas. Radiology. 1969;93(6):1351-1359.
18. Shih DJ, Northcott PA, Remke M, et al. Cytogenetic prognostication within medulloblastoma subgroups. J Clin Oncol. 2014;32(9): 886-896.
19. Kool M, Koster J, Bunt J, et al. Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One. 2008;3(8): e3088.
20. Ang C, Hauerstock D, Guiot MC, et al. Characteristics and outcomes of medulloblastoma in adults. Pediatr Blood Cancer. 2008;51(5):603-607.
21. Remke M, Hielscher T, Northcott PA, et al. Adult medulloblastoma comprises three major molecular variants. J Clin Oncol. 2011; 29(19):2717-2723.
22. Rutkowski S, von Hoff K, Emser A, et al. Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis. J Clin Oncol. 2010;28(33):4961-4968.
23. Eberhart CG, Kepner JL, Goldthwaite PT, et al. Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study. Cancer. 2002;94(2):552-560.
24. Rutkowski S, Bode U, Deinlein F, et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med. 2005;352(10):978-986.
25. Giangaspero F, Rigobello L, Badiali M, et al. Large-cell medulloblastomas. A distinct variant with highly aggressive behavior. Am J Surg Pathol. 1992;16:687-693.
26. Brown HG, Kepner JL, Perlman EJ, et al. "Large cell/anaplastic" medulloblastomas: a Pediatric Oncology Group study. J Neuropathol Exp Neurol. 2000;59:857-865.
27. Dunkel IJ, Gardner SL, Garvin JH Jr, et al. High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma. Neuro Oncol. 2010;12(3):297-303.
28. Carrie C, Lasset C, Alapetite C, et al. Multivariate analysis of prognostic factors in adult patients with medulloblastoma. Retrospective study of 156 patients. Cancer. 1994;74(8):2352-2360.
29. Brandes AA, Franceschi E, Tosoni A, et al. Long-term results of a prospective study on the treatment of medulloblastoma in adults. Cancer. 2007;110(9):2035-2041.